Lactated Ringer's Solution in Neonates With Feeding Intolerance (LR)
Enteral Administration of Lactated Ringer's Solution in Neonates With Feeding Intolerance, a Randomized Controlled Trial
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Listed as NCT01236833, this PHASE2 trial focuses on Feeding Disorder Neonatal and Intestinal Disease and remains ongoing. Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Oct 2019 — Jan 2021 [monthly]
Unknown Status PHASE2
-
Jun 2018 — Oct 2019 [monthly]
Unknown Status PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- McGill University Health Centre/Research Institute of the McGill University Health Centre
For direct contact, visit the study record on ClinicalTrials.gov .